Evaluating Ligand Modifications of the Titanocene and Auranofin Moieties for the Development of More Potent Anticancer Drugs

Evaluating Ligand Modifications of the Titanocene and Auranofin Moieties for the Development of More Potent Anticancer Drugs

Over time platinum-based anticancer drugs have dominated the market, but their side effects significantly impact the quality of life of patients. Alternative treatments are being developed all over the world. The titanocene and auranofin families of compounds, discovered through an empirical search...

Full description

Bibliographic Details
Main Authors: Lauren Fernández-Vega, Valeria A. Ruiz Silva, Tania M. Domínguez-González, Sebastián Claudio-Betancourt, Rafael E. Toro-Maldonado, Luisa C. Capre Maso, Karina Sanabria Ortiz, Jean A. Pérez-Verdejo, Janeishly Román González, Grecia T. Rosado-Fraticelli, Fabiola Pagán Meléndez, Fabiola M. Betancourt Santiago, Daniel A. Rivera-Rivera, Carlos Martínez Navarro, Andrea C. Bruno Chardón, Axel O. Vera, Arthur D. Tinoco
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Inorganics
Subjects:
titanocene
auranofin
anticancer metallodrugs
ligand design
functionalized ligands
Online Access:https://www.mdpi.com/2304-6740/8/2/10

Internet

https://www.mdpi.com/2304-6740/8/2/10

Similar Items